ANNX Competitors & Alternatives
Compare Annexon Inc with similar stocks in the same industry
Biotechnology
ANNX
Main Stock$5.21
Tradestie Score
51
Market Cap
$332.96M
Analyst Upside
+160.4%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TNGX
Tango Therapeutics, Inc.
|
$27.24
|
$887.30M | - | 62 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.39
|
$879.90M | 5.1 | 51 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$8.92
|
$871.90M | - | 52 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$8.88
|
$868.46M | - | 53 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$5.84
|
$867.49M | - | 54 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$19.20
|
$864.42M | - | 56 | Compare |
|
CRMD
CorMedix Inc.
|
$7.45
|
$862.55M | 3.3 | 49 | Compare |
|
SEPN
Septerna, Inc. Common Stock
|
$34.72
|
$847.12M | - | 51 | Compare |
|
XNCR
Xencor, Inc.
|
$19.30
|
$843.75M | - | 53 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$28.14
|
$841.74M | - | 57 | Compare |
More ANNX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry